Bottom Line:
Publication details:
We assessed this page using an appraisal instrument developed by Minervation specifically for this project. This approach is still in development, so you should regard the assessments as a general guide. Click here to find out more, or to let us know how you think the approach could be improved.
Reliability comments:
- The site does not report any quality assurance process for content.
- Pages are reviewed by an individual doctor.
Usability comments:
- The site provides good, readable information about the basics of prostate disease, tests and treaments.
- The site is less helpful in finding detailed information that is specific to a particular stage of disease.
Scoring
Reliability
| Item |
Score |
| Is it clear who has developed the web site and what their objectives are? |
3 |
|
|
| Does the site report a robust quality control procedure? |
0 |
| No content management procedure is reported. |
| Is the page content checked by an expert? |
3 |
|
|
| Is the page updated regularly? |
3 |
|
|
| Does the page cite relevant sources where appropriate? |
0 |
| This type of treatment summary needs to show the evidence it is based on and provide onward links to more information. |
Usability
| Item |
Score |
| Is the site accessible without a login? |
3 |
|
|
| Does the site conform to web Accessibility standards? |
3 |
| LIDA score 93%. Keyword metadata is lacking. |
| Is the site design clear and transparent? |
3 |
|
|
| Is the site design consistent from one page to another? |
2 |
| There are some inconsistencies in the information architecture, in terms of the detail provided. For example, side effects are given for some but not all treatment options. |
| Can users find what they need on the site? |
2 |
| Search engine did not perform well in a complex search. It is hard to find information that is specific to a particular stage or grade of prostate cancer. |
| Is the format of information clear and appropriate for the audience? |
2 |
| The information would benefit from an introduction, putting these developments in context. |
| Weighted total (Usability + (Reliability x 2)): |
33 |
We score each question out of three where:
| 0 |
= Never or Can't tell |
| 1 |
= Sometimes or partly |
| 2 |
= Mostly |
| 3 |
= Always |
|
New treatments
